Premium
Prognostic value of breast cancer aromatase
Author(s) -
Lipton Allan,
Santen Richard J.,
Santner Steven J.,
Harvey Harold A.,
Sanders Sherry I.,
Matthews Yvonne L.
Publication year - 1992
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/1097-0142(19921001)70:7<1951::aid-cncr2820700723>3.0.co;2-#
Subject(s) - aromatase , medicine , breast cancer , estrogen , estrogen receptor , receptor , cancer , endocrinology , progesterone receptor , oncology
The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease‐free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease‐free interval or survival. Cancer 1992; 70:1951‐1955.